Announcements Trials
Browse Landscape

Status

Unknown 2Recruiting 1Completed 1

Sponsor Class

OTHER 2031INDUSTRY 315NIH 172OTHER_GOV 72NETWORK 29UNKNOWN 4FED 1

Study Type

Interventional 6Observational 4

Sponsor

Cancer Type

Tumor-Agnostic 3Lymphoid 1

Conditions

Esophageal Neoplasms 7Breast Neoplasms 6Rectal Neoplasms 4Neoplasms 4Radiation Injuries 2Lymphoma, Large B-Cell, Diffuse 2Lung Neoplasms 2Hormone Receptor Positive Advanced Breast Cancer 2Brain Neoplasms 2Varicose Veins 1Syphilis 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Skin Neoplasms 1Recurrence 1Pathologic Complete Response 1Papillomavirus Infections 1Mesothelioma, Malignant 1Lymphoid Neoplasm 1Lymphocele 1Hyperparathyroidism, Primary 1Hypercalcemia 1Head and Neck Neoplasms 1HIV Infections 1HER2-positive Breast Cancer 1Cardiovascular Diseases 1Carcinoma, Ovarian Epithelial 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
UNKNOWN × Observational × Neoplasms × Clear all
NCT06625203 2024-10-03

MOSAIC

OWKIN

Recruiting
7,000 enrolled
Lymphoid

Neoplasms, Lymphoma, Large B-Cell, Diffuse

NCT03412344 2018-01-26

Factors Influencing Cancer Patients Participation in Clinical Trials in China.

ChineseAMS

Unknown
300 enrolled
Tumor-Agnostic

Neoplasms

NCT03039062 2017-03-30

Serum miR-122 as a Real-time Detection Biomarker of Drug-induced Liver Injury by Chemotherapy

ChineseAMS

Unknown
180 enrolled
Tumor-Agnostic

Neoplasms

NCT02024321 2013-12-31

TPN

ChineseAMS

Completed
86 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡